Raymond James & Associates’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,538
| Closed | -$20.6K | – | 3966 |
|
|
2024
Q2 | $20.6K | Sell |
1,538
-2,921
| -66% | -$39.1K | ﹤0.01% | 3844 |
|
|
2024
Q1 | $207K | Sell |
4,459
-33
| -0.7% | -$1.53K | ﹤0.01% | 3570 |
|
|
2023
Q4 | $304K | Sell |
4,492
-348
| -7% | -$23.5K | ﹤0.01% | 3248 |
|
|
2023
Q3 | $350K | Buy |
4,840
+212
| +5% | +$15.3K | ﹤0.01% | 3081 |
|
|
2023
Q2 | $344K | Buy |
4,628
+260
| +6% | +$19.3K | ﹤0.01% | 3131 |
|
|
2023
Q1 | $232K | Buy |
4,368
+201
| +5% | +$10.7K | ﹤0.01% | 3378 |
|
|
2022
Q4 | $282K | Sell |
4,167
-312
| -7% | -$21.1K | ﹤0.01% | 3236 |
|
|
2022
Q3 | $559K | Buy |
4,479
+1,466
| +49% | +$183K | ﹤0.01% | 2778 |
|
|
2022
Q2 | $287K | Buy |
3,013
+790
| +36% | +$75.3K | ﹤0.01% | 3247 |
|
|
2022
Q1 | $358K | Buy |
2,223
+1,667
| +300% | +$268K | ﹤0.01% | 3269 |
|
|
2021
Q4 | $185K | Sell |
556
-657
| -54% | -$219K | ﹤0.01% | 3689 |
|
|
2021
Q3 | $562K | Buy |
+1,213
| New | +$562K | ﹤0.01% | 2971 |
|